An upregulation of claudin-2 was also detected in cutaneous SCC [11], colorectal cancer [29,30], and endometrioid endometrial adenocarcinoma [31], and in two-thirds of examined lung adenocarcinoma samples [32]. Here, CLDN2 is linked to colorectal cancer.